Delivery Order SPE2DB22D2218-SPE2DB24FR2QP
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.46 firm fixed-price delivery order is for the supply of 4,565,548,469 tablets of the drug Dapagliflozin 10 mg, with a period of performance through August 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,316.64 Firm Fixed Price Delivery Order contract is for the supply of Dapagliflozin 10 mg tablets to support federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,754.38 firm fixed-price delivery order is for the supply of the drug Dapagliflozin 10 mg tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,019.06 firm fixed-price delivery order is for the supply of 4,565,286,170 units of the drug Dapagliflozin 10 mg Tablets, with an ultimate completion date of July 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,100.24 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used in diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,639.50 firm-fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets to support military healthcare programs. The contract has an ultimate completion date of March 18, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,398.54 Firm Fixed Price Delivery Order contract is for the supply of the medication Dapagliflozin 10 mg tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.67 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used for the treatment of Type 2 diabetes. The contract has an ultimate completion date of October 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,351.80 firm-fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a prescription medication. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,790.60 firm fixed-price delivery order is for the supply of 4565046760 - Dapagliflozin 10 mg Tablets, with a period of performance through July 2, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2QPDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,099.70 firm fixed-price delivery order is for the supply of 4,564,676,064 units of the drug Dapagliflozin 10 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the provision of essential pharmaceutical products. AmerisourceBergen's extensive experience and capabilities in the federal healthcare supply chain make it a critical vendor for the DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 5/21/24 |